Table 1 Relationship between DACH1 expression and clinicopathological characteristics in 120 LSCC patients
From: Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma
Clinicopathological characteristics | DACH1 | expression | p-value |
|---|---|---|---|
<mean value% | ≥mean value% | ||
N = 120 | 60 (50.0%) | 60 (50.0%) | |
Age (mean ± SD; years) | 0.239 | ||
< 61 ± 8.11 | 38 (31.7%) | 44 (36.7%) | |
≥ 61 ± 8.11 | 22 (18.3%) | 16 (13.3%) | |
Gender | 0.194 | ||
Male | 32 (26.7%) | 39 (32.5%) | |
Female | 28 (23.3%) | 21 (17.5%) | |
T classification | 0.002 | ||
T1-T2 | 49 (40.8%) | 33 (27.5%) | |
T3-T4 | 11 (9.2%) | 27 (22.5%) | |
Lymph node metastases | 0.010 | ||
Yes | 40 (33.3%) | 52 (43.3%) | |
No | 20 (16.7%) | 8 (6.7%) | |
Primary location | 0.006 | ||
Supraglottic | 41 (34.2%) | 26 (21.7%) | |
Glottic | 19 (15.8%) | 34 (28.3%) | |
Differentiation | 0.099 | ||
G1 | 23 (19.2%) | 32 (26.7%) | |
G2-G3 | 37 (30.8%) | 28 (23.3%) | |
Clinical stage | 0.016 | ||
I-II | 29 (24.2%) | 42 (35.0%) | |
III-IV | 31 (2ss5.8%) | 18 (15.0%) | |
Smoking | 0.002 | ||
Never | 4 (3.3%) | 17 (14.2%) | |
Ever | 56 (46.7%) | 43 (35.8%) | |
Drinking | 0.039 | ||
Never | 11 (9.2%) | 21 (17.5%) | |
Ever | 49 (40.8%) | 39 (32.5%) |